Sonora Investment Management Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,647
Closed -$283K 305
2025
Q1
$283K Buy
4,647
+132
+3% +$7.69K 0.02% 227
2024
Q4
$255K Sell
4,515
-1,245
-22% -$69.6K 0.02% 236
2024
Q3
$298K Sell
5,760
-3,572
-38% -$168K 0.02% 221
2024
Q2
$506K Hold
9,332
0.04% 173
2024
Q1
$506K Buy
9,332
+523
+6% +$26.6K 0.04% 173
2023
Q4
$452K Buy
8,809
+1,753
+25% +$92K 0.04% 172
2023
Q3
$410K Sell
7,056
-184
-3% -$11.3K 0.04% 176
2023
Q2
$463K Buy
7,240
+241
+3% +$16.2K 0.04% 164
2023
Q1
$485K Sell
6,999
-537
-7% -$37.9K 0.04% 158
2022
Q4
$542K Buy
7,536
+285
+4% +$21.5K 0.05% 155
2022
Q3
$558K Hold
7,251
0.07% 122
2022
Q2
$558K Buy
7,251
+1,451
+25% +$111K 0.05% 153
2022
Q1
$423K Buy
5,800
+325
+6% +$21.8K 0.05% 143
2021
Q4
$341K Buy
+5,475
New +$321K 0.04% 163

Other funds holding BMY

Sonora Investment Management Group's BMY Position: Q2 2025 in Review

Sonora Investment Management Group sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 4,647 shares — an estimated $283K sold.

Sonora Investment Management Group first reported a position in BMY in Q4 2021 and held it in 14 quarters. The position peaked at $558K in Q3 2022. 2,293 funds tracked by Wall St. Rank hold BMY as of Q2 2025.

  • Sonora Investment Management Group reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
  • Sonora Investment Management Group sold 4,647 Bristol-Myers Squibb shares in Q2 2025, an estimated $283K.
  • Sonora Investment Management Group first reported a position in Bristol-Myers Squibb in Q4 2021 and held it in 14 quarters.
  • Sonora Investment Management Group's Bristol-Myers Squibb position peaked at $558K in Q3 2022.
  • 2,293 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.

Based on Sonora Investment Management Group's 13F filing for Q2 2025, filed 17 Jul 2025.